superficial arteriovenous malformations research hub

MAV-RAPA: Prospective evaluation of the efficacy of sirolimus (Rapamune) in the treatment of superficial arteriovenous malformations.

This study looks at how well a medicine called Rapamune works for people with certain abnormal blood vessel growths. Researchers want to see if it can shrink these growths, known as arteriovenous malformations (AVMs), in adult patients.